Norcliffe Capital are proud to support ClinSpec Diagnostics Ltd and the future of cancer diagnostics. ClinSpec Dx, a Glasgow based spin out from the University of Strathclyde, have developed a cancer diagnostics system using a simple blood test analysis to accelerate the time it takes to diagnose cancer. Based on the world-leading research of Dr Matthew Baker,...
7 Bell Yard, London, WC2A 2JR
enquiries@norcliffe.capital